drugset / Trial / NCT01505296

Catheter Ablation for Recently Diagnosed Paroxysmal Atrial Fibrillation

NCT01505296 ↗

RandomizedParallel-groupOpen-labelTreatment

Summary

The objective is to compare the progression of Atrial Fib (AF) burden by continuous monitoring in patients with recently diagnosed paroxysmal AF treated by catheter ablation (PVI) versus anti-arrhythmic drug (AAD) therapy.

Timeline

Start
2011-12
Primary completion
2014-01
Completion
2014-01

Outcome

Outcome not reported

Stopped: “Never initiated”

Drugs

EvaluationDrugModalityDoseRoute
Subject Dofetilide Small molecule — —
Subject flecainide Small molecule — —
Subject propafenone Unknown — —
Subject sotalol Small molecule — —

Indications